NewswireToday - /newswire/ -
San Jose, CA, United States, 2008/08/27 - AnaSpec and UW TechTransfer announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent #5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases”.
AnaSpec, Inc. and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent #5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.”
"We are pleased to partner with UW TechTransfer to provide our customers with one of the largest selections of research-ready peptides in the industry," noted Dr. Anita Hong, AnaSpec's president. "The patented protein tyrosine phosphatase substrates will be a welcome addition to AnaSpec’s signature family of GO™ Peptides."
"We're all about pushing UW technologies into the marketplace so we are thrilled that AnaSpec will be offering this patented technology to an expanding collection of researchers," stated Linden Rhoads, vice provost, UW TechTransfer.
About AnaSpec, Inc.
AnaSpec, Inc. (anaspec.com) is a leading provider of integrated proteomics solutions™ for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry.
About UW TechTransfer
Established in 1982, UW TechTransfer facilitates the commercialization of new innovations arising from UW research through the management and licensing of intellectual property. Since the department's founding, UW TechTransfer has helped create more than 235 companies in Washington state and abroad. In FY07, UW TechTransfer generated $38 million in total revenue from all sources. Additionally, UW TechTransfer manages a total patent portfolio of over 2000 issued and pending patents filed in the U.S. and around the world.